198 related articles for article (PubMed ID: 34760046)
1. Astragaloside IV Inhibits Bleomycin-Induced Ferroptosis in Human Umbilical Vein Endothelial Cells by Mediating LPC.
Sheng S; Xu J; Liang Q; Hong L; Zhang L
Oxid Med Cell Longev; 2021; 2021():6241242. PubMed ID: 34760046
[TBL] [Abstract][Full Text] [Related]
2. 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside protects human umbilical vein endothelial cells against lysophosphatidylcholine-induced apoptosis by upregulating superoxide dismutase and glutathione peroxidase.
Zhao J; Xu S; Song F; Nian L; Zhou X; Wang S
IUBMB Life; 2014 Oct; 66(10):711-22. PubMed ID: 25382724
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV regulates the ferroptosis signaling pathway via the Nrf2/SLC7A11/GPX4 axis to inhibit PM2.5-mediated lung injury in mice.
Wang X; Wang Y; Huang D; Shi S; Pei C; Wu Y; Shen Z; Wang F; Wang Z
Int Immunopharmacol; 2022 Nov; 112():109186. PubMed ID: 36115280
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV ameliorates spinal cord injury through controlling ferroptosis in H
Zhou Y; Li L; Mao C; Zhou D
Ann Transl Med; 2022 Nov; 10(21):1176. PubMed ID: 36467371
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV Protects Against Oxidized Low-Density Lipoprotein (ox-LDL)-Induced Endothelial Cell Injury by Reducing Oxidative Stress and Inflammation.
Zhu Z; Li J; Zhang X
Med Sci Monit; 2019 Mar; 25():2132-2140. PubMed ID: 30901320
[TBL] [Abstract][Full Text] [Related]
6. Pro-angiogenic activity of astragaloside IV in HUVECs in vitro and zebrafish in vivo.
Zhang Y; Hu G; Li S; Li ZH; Lam CO; Hong SJ; Kwan YW; Chan SW; Leung GP; Lee SM
Mol Med Rep; 2012 Mar; 5(3):805-11. PubMed ID: 22179585
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV inhibits doxorubicin-induced cardiomyocyte apoptosis mediated by mitochondrial apoptotic pathway via activating the PI3K/Akt pathway.
Jia Y; Zuo D; Li Z; Liu H; Dai Z; Cai J; Pang L; Wu Y
Chem Pharm Bull (Tokyo); 2014; 62(1):45-53. PubMed ID: 24390491
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV ameliorates cisplatin-induced liver injury by modulating ferroptosis-dependent pathways.
Guo J; Le Y; Yuan A; Liu J; Chen H; Qiu J; Wang C; Dou X; Yuan X; Lu D
J Ethnopharmacol; 2024 Jun; 328():118080. PubMed ID: 38521426
[TBL] [Abstract][Full Text] [Related]
9. Platycodin D regulates high glucose-induced ferroptosis of HK-2 cells through glutathione peroxidase 4 (GPX4).
Huang J; Chen G; Wang J; Liu S; Su J
Bioengineered; 2022 Mar; 13(3):6627-6637. PubMed ID: 35226829
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of astragaloside IV against amyloid beta1-42 neurotoxicity by inhibiting the mitochondrial permeability transition pore opening.
Sun Q; Jia N; Wang W; Jin H; Xu J; Hu H
PLoS One; 2014; 9(6):e98866. PubMed ID: 24905226
[TBL] [Abstract][Full Text] [Related]
11. Astragaloside IV stimulates angiogenesis and increases hypoxia-inducible factor-1α accumulation via phosphatidylinositol 3-kinase/Akt pathway.
Zhang L; Liu Q; Lu L; Zhao X; Gao X; Wang Y
J Pharmacol Exp Ther; 2011 Aug; 338(2):485-91. PubMed ID: 21576377
[TBL] [Abstract][Full Text] [Related]
12. AST IV inhibits H₂O₂-induced human umbilical vein endothelial cell apoptosis by suppressing Nox4 expression through the TGF-β1/Smad2 pathway.
Ma Y; Li W; Yin Y; Li W
Int J Mol Med; 2015 Jun; 35(6):1667-74. PubMed ID: 25891879
[TBL] [Abstract][Full Text] [Related]
13. The BCL2/BAX/ROS pathway is involved in the inhibitory effect of astragaloside IV on pyroptosis in human umbilical vein endothelial cells.
Su Y; Yin X; Huang X; Guo Q; Ma M; Guo L
Pharm Biol; 2022 Dec; 60(1):1812-1818. PubMed ID: 36121248
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV improves homocysteine-induced acute phase endothelial dysfunction via antioxidation.
Qiu LH; Xie XJ; Zhang BQ
Biol Pharm Bull; 2010; 33(4):641-6. PubMed ID: 20410599
[TBL] [Abstract][Full Text] [Related]
15. Icariin, astragaloside a and puerarin mixture attenuates cognitive impairment in APP/PS1 mice via inhibition of ferroptosis-lipid peroxidation.
Zhang TC; Lin YC; Sun NN; Liu S; Hu WZ; Zhao Y; Dong XH; He XP
Neurochem Int; 2024 May; 175():105705. PubMed ID: 38412923
[TBL] [Abstract][Full Text] [Related]
16. Engeletin alleviates erastin-induced oxidative stress and protects against ferroptosis via Nrf2/Keap1 pathway in bone marrow mesenchymal stem cells.
Huang L; Bian M; Lu S; Wang J; Yu J; Jiang L; Zhang J
Tissue Cell; 2023 Jun; 82():102040. PubMed ID: 36857798
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidylcholine promotes intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression in human umbilical vein endothelial cells via an orphan G protein receptor 2-mediated signaling pathway.
Zhang Q; Zhang W; Liu J; Yang H; Hu Y; Zhang M; Bai T; Chang F
Bioengineered; 2021 Dec; 12(1):4520-4535. PubMed ID: 34346841
[TBL] [Abstract][Full Text] [Related]
18. Astragaloside IV and cycloastragenol are equally effective in inhibition of endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation in the endothelium.
Zhao Y; Li Q; Zhao W; Li J; Sun Y; Liu K; Liu B; Zhang N
J Ethnopharmacol; 2015 Jul; 169():210-8. PubMed ID: 25922268
[TBL] [Abstract][Full Text] [Related]
19. Effects of chlorogenic acid on intracellular calcium regulation in lysophosphatidylcholine-treated endothelial cells.
Jung HJ; Im SS; Song DK; Bae JH
BMB Rep; 2017 Jun; 50(6):323-328. PubMed ID: 28088946
[TBL] [Abstract][Full Text] [Related]
20. CTRP13 Mitigates Endothelial Cell Ferroptosis via the AMPK/KLF4 Pathway: Implications for Atherosclerosis Protection.
Du J; Wu J; Zhang Y; Liu Q; Luo X; Huang X; Wang X; Yang F; Hou J
Med Sci Monit; 2024 Jan; 30():e942733. PubMed ID: 38273650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
